JPMorgan Chase & Co. Issues Positive Forecast for Colgate-Palmolive (NYSE:CL) Stock Price

Key Points

• JPMorgan Chase raised its price target on Colgate‑Palmolive from $95 to $96 and kept an overweight rating, implying roughly a 12.6% upside from the prior close.
• Colgate beat quarterly estimates with $0.97 EPS (vs. $0.94) and $5.32B revenue (up 8.4% year‑over‑year), but the stock traded down about 2.3% to $85.28 and remains below the consensus price target of $95.81.
• Insiders have sold about 184,683 shares (≈$17.5M) in the past 90 days, leaving insiders with just 0.43% ownership, a factor that may affect investor sentiment.

Colgate-Palmolive (NYSE:CL - Get Free Report) had its target price raised by investment analysts at JPMorgan Chase & Co. from $95.00 to $96.00 in a report issued on Monday,Benzinga reports. The brokerage currently has an "overweight" rating on the stock. JPMorgan Chase & Co.'s target price suggests a potential upside of 12.57% from the company's previous close.

A number of other research analysts have also commented on the company. Rothschild & Co Redburn set a $100.00 price target on Colgate-Palmolive and gave the company a "buy" rating in a research report on Tuesday, April 21st. Deutsche Bank Aktiengesellschaft reissued a "buy" rating and issued a $99.00 target price on shares of Colgate-Palmolive in a research report on Monday. Bank of America decreased their target price on Colgate-Palmolive from $105.00 to $102.00 and set a "buy" rating for the company in a research report on Friday, April 10th. Wells Fargo & Company decreased their target price on Colgate-Palmolive from $100.00 to $92.00 and set an "equal weight" rating for the company in a research report on Wednesday, April 8th. Finally, Weiss Ratings reissued a "hold (c)" rating on shares of Colgate-Palmolive in a research report on Wednesday, January 21st. Twelve investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $95.81.

Colgate-Palmolive Trading Down 2.3%

CL traded down $1.98 during midday trading on Monday, reaching $85.28. 4,626,770 shares of the company's stock traded hands, compared to its average volume of 6,656,054. The firm has a fifty day moving average of $87.95 and a two-hundred day moving average of $84.15. The stock has a market capitalization of $68.42 billion, a price-to-earnings ratio of 33.18, a P/E/G ratio of 4.46 and a beta of 0.31. The company has a debt-to-equity ratio of 18.82, a current ratio of 0.44 and a quick ratio of 0.29. Colgate-Palmolive has a 52 week low of $74.54 and a 52 week high of $99.33.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings results on Friday, May 1st. The company reported $0.97 EPS for the quarter, beating analysts' consensus estimates of $0.94 by $0.03. The business had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.22 billion. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.Colgate-Palmolive's quarterly revenue was up 8.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.91 EPS. On average, equities analysts anticipate that Colgate-Palmolive will post 3.85 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, insider Sally Massey sold 15,851 shares of the firm's stock in a transaction that occurred on Thursday, February 5th. The stock was sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the completion of the transaction, the insider owned 13,751 shares of the company's stock, valued at $1,306,757.53. This trade represents a 53.55% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Stanley J. Sutula III sold 97,843 shares of the firm's stock in a transaction that occurred on Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total value of $9,223,659.61. Following the transaction, the chief financial officer directly owned 55,310 shares of the company's stock, valued at approximately $5,214,073.70. This trade represents a 63.89% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 184,683 shares of company stock worth $17,486,693 in the last 90 days. Corporate insiders own 0.43% of the company's stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Kemnay Advisory Services Inc. bought a new position in Colgate-Palmolive during the 4th quarter valued at approximately $25,000. CBIZ Investment Advisory Services LLC increased its position in Colgate-Palmolive by 86.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company's stock valued at $26,000 after buying an additional 150 shares in the last quarter. TD Capital Management LLC increased its position in Colgate-Palmolive by 61.4% during the 4th quarter. TD Capital Management LLC now owns 326 shares of the company's stock valued at $26,000 after buying an additional 124 shares in the last quarter. Triumph Capital Management boosted its stake in Colgate-Palmolive by 62.9% during the 4th quarter. Triumph Capital Management now owns 329 shares of the company's stock valued at $26,000 after purchasing an additional 127 shares during the last quarter. Finally, Jessup Wealth Management Inc purchased a new stake in Colgate-Palmolive during the 4th quarter valued at $26,000. Institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company's core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.